Major Pharmaceutical Conferences.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 349, doi. 10.1007/BF03256790
- Publication type:
- Article
Works matching IS 11782595 AND DT 2009 AND VI 23 AND IP 5/6
Results: 14
1
2
Key Performance Indicators of Clinical Trials in Japan.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 305, doi. 10.1007/BF03256786
- By:
- Publication type:
- Article
3
Xenoestrogens.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
4
The Pharmaceutical Medicine Year that Was.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
5
Surrogate Efficacy Endpoints in Oncology Trials.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
6
Strategies to Measure and Improve Patient Adherence in Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 289, doi. 10.1007/BF03256784
- By:
- Publication type:
- Article
7
Preparing for Regulatory Review and Reimbursement Decisions.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
8
Pharmacoeconomics in Healthcare Decision Making in China.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
9
Journal Watch.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 331, doi. 10.1007/BF03256789
- Publication type:
- Article
10
Interpersonal Values of Healthy Subjects Who Volunteer for Phase I Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 299, doi. 10.1007/BF03256785
- By:
- Publication type:
- Article
11
From the Seven Deadly Sins to a Risk Management Plan.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
12
Forum.
- Published in:
- Pharmaceutical Medicine, 2009, v. 23, n. 5/6, p. 311, doi. 10.1007/BF03256788
- Publication type:
- Article
13
A Reflection on Fraud and Misconduct in Biomedical Research.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
14
2nd Annual New Zealand Pharmaceutical Management Agency Forum.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding